My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Pfizer (NY:PFE)

27.45 +0.07 (+0.27%)

Streaming Delayed Price Updated: 2:13 PM EST, Feb 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

39 40 Next >

A Comprehensive Study Exploring Balantidiasis Market : Key Players Fougera Pharmaceuticals, Medtronic, NuVasive

January 24, 2023

Get Balantidiasis Market analysis, key vendors & competitive scenario of the market prepared using market research tools such as Porter’s five forces and SWOT analysis.

Via SBWire

Capturing the U.S. Health Care Space with XLV

January 23, 2023

Via Get News

Topics ETFs

When Does Pfizer Become A Bargain?

January 23, 2023

With a price-to-earnings ratio of less than 9 and a dividend yield of 3.63% you have to be thinking that Pfizer may a bit of a bargain down here.

Via MarketBeat

Tumor Lysis Syndrome Market Projected to Show Strong Growth : AbbVie, Hikma Pharmaceuticals, Amgen, Genentech

January 23, 2023

Get an extensive Tumor Lysis Syndrome Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.

Via SBWire

Is C3.ai Stock a ChatGPT Artificial Intelligence Play?

January 23, 2023

Via MarketBeat

Topics Artificial Intelligence

Moderna and Pfizer Race to Release RSV Vaccines

January 19, 2023

Two of the largest vaccine producers have engaged in the rapid development of RSV vaccines, here's how the companies are tracking so far.

Via MarketBeat

AbbVie Stock: Dividend King ABBV Overview

January 19, 2023

Via MarketBeat

Drug Delivery Market – Major Technology Giants in Buzz Again : Johnson & Johnson, Sanofi, Pfizer

January 18, 2023

How to reach that market place and its associated audience with current marketing efforts? Benchmark now the competitive efforts with high growth emerging players and leaders of Drug Delivery Market.

Via SBWire

Health and Beauty Products Market to Eyewitness Massive Growth by 2028 : Wallgreen, Coty, Nestle

January 18, 2023

Stay up-to-date with Health and Beauty Products Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.

Via SBWire

Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?

January 18, 2023

Johnson & Johnson stock has been struggling to break out of a correction. It formed a cup-shaped pattern that appeared to add a handle but broke down last week.

Via MarketBeat

Topics Stocks

Pfizer Expands ‘An Accord for a Healthier World’ Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries

January 17, 2023

From Pfizer Inc.

Via Business Wire

"CDC, FDA…link between Pfizer's shot & strokes" 2 years after FDA warning; Media Failing US: Expert

January 15, 2023

January 15, 2023 -- FDA's warning of death, strokes, and serious reactions from the shot posted at https://www.fda.gov/media/143557/download pg 16 Oct 22, 2020 were never reported by media, says...

Via 24-7 Press Release

Direct to Consumer Pharmaceutical Advertising Market Is Going to Boom : Pfizer, Merck, GlaxoSmithKline

January 11, 2023

Stay up-to-date with Direct To Consumer Pharmaceutical Advertising Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.

Via SBWire

Atypical Digital, A Global Digital Marketing Tech Enabled Company, acquires South Korea-based Springworks

January 10, 2023

Via AB Newswire

Four Undervalued Healthcare Stocks for 2023

January 06, 2023

These four health care stocks could be undervalued: Pfizer Inc., Regeneron Pharmaceuticals Inc., Innoviva Inc. and Exelixis Inc.

Via MarketBeat

A Comprehensive Study Exploring Nephroblastoma Treatment Market: Key Players Bayer HealthCare, Pfizer, AstraZeneca

January 06, 2023

Get an extensive Nephroblastoma Treatment Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.

Via SBWire

U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine in Infants and Children

January 06, 2023

From Pfizer Inc.

Via Business Wire

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

January 03, 2023

From Pfizer Inc.

Via Business Wire

The Year of the Tripledemic

January 03, 2023

COVID-19 may have lost its daily news headline status, but the disease rages on with 2700 weekly deaths in the U.S. and millions of Americans chronically disabled from long-COVID, 4 million of which...

Via TheNewswire.com

Topics Death

Pfizer Announces Positive Top-Line Results from Phase 3 Study of Hemophilia B Gene Therapy Candidate

December 29, 2022

From Pfizer Inc.

Via Business Wire

Big Health Care Stocks to Watch in the New Year

December 29, 2022

Here are three health care stocks to watch as the New Year begins. Two have a moderate Buy rating while one is a Hold, for now.

Via MarketBeat

DeepThink Health Appoints Krish Ghosh as Executive Vice President and General Manager, Life Sciences

December 28, 2022

Ghosh Brings Three Decades of Life Sciences Experience to DeepThink HealthSAN RAMON, Calif. - Dec. 28, 2022 - PRLog -- DeepThink Health, Inc., an AI-powered leader in the transformation of health data...

Via PRLog

Topics Artificial Intelligence

U.S. FDA Accepts for Review the Biologics License Application for Pfizer’s Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents

December 28, 2022

From Pfizer Inc.

Via Business Wire

Why Did Immutep Ltd Stock Soar Recently?

December 28, 2022

Analysts and investors alike appear enamored with Immutep Ltd, whose earnings are growing; more of which could come from their latest product candidate.

Via MarketBeat

Topics Initial Public Offering

Vaccines & Vaccination Market May Set Epic Growth Story : Pfizer, Merck, Johnson & Johnson

December 22, 2022

Stay up-to-date with Vaccines & Vaccination Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.

Via SBWire

Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis

December 21, 2022

From Pfizer Inc.

Via Business Wire

Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts

December 20, 2022

From Pfizer Inc.

Via Business Wire

Eli Lilly Expects Enduring Growth, Despite Immediate Challenges

December 19, 2022

Eli Lilly & Co may be struggling with supply-side issues but new partnerships and a healthy dividend are helping to keep up their momentum

Via MarketBeat

Pfizer Opts In to LianBio Rights to Respiratory Syncytial Virus Therapeutic Candidate Sisunatovir in Mainland China, Hong Kong, Macau, and Singapore

December 19, 2022

From LianBio; Pfizer Inc.

Via GlobeNewswire

BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients

December 14, 2022

Small and big pharma companies such as Pfizer Inc. (NYSE: PFE), Celldex Therapeutics Inc. (NASDAQ: CLDX), and Hologic Inc. (NASDAQ: HOLX) are ramping up efforts to help reduce or eliminate the growing...

Via TheNewswire.com

Topics Death

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

39 40 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.